Do analysts rate AVD or BIOX?

Bioceres Crop Solutions has a consensus target price of $2.00, indicating a potential upside of 509.20%. Given Bioceres Crop Solutions' stronger consensus rating and higher probable upside, analysts plainly believe Bioceres Crop Solutions is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bioceres Crop Solutions 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Do analysts rate AVD or SNES?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Senestech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate CTVA or AVD?

Corteva presently has a consensus target price of $64.00, suggesting a potential upside of 383.60%. Given Corteva's stronger consensus rating and higher possible upside, equities analysts clearly believe Corteva is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Corteva 1 Sell rating(s) 6 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.65 American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend AVD or NTR?

Nutrien has a consensus price target of $81.15, suggesting a potential upside of 20.20%. Given Nutrien's stronger consensus rating and higher possible upside, analysts clearly believe Nutrien is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nutrien 1 Sell rating(s) 4 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.73

Do analysts prefer AVD or CF?

CF Industries has a consensus price target of $121.11, suggesting a potential upside of 8.45%. Given CF Industries' stronger consensus rating and higher possible upside, analysts plainly believe CF Industries is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CF Industries 3 Sell rating(s) 12 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.30

American Vanguard (AVD) Competitors

$1.62 -0.09 (-5.44%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$1.60 -0.02 (-1.05%)

As of 10/9/2026 07:30 PM Eastern

Compare

AVD vs. BIOX, SNES, CTVA, NTR, and CF

Should you buy American Vanguard stock or one of its competitors? American Vanguard's main competitors and comparable companies include Bioceres Crop Solutions (BIOX), Senestech (SNES), Corteva (CTVA), Nutrien (NTR), and CF Industries (CF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "fertilizers & agricultural chemicals" industry.

How does American Vanguard compare to Bioceres Crop Solutions?

American Vanguard (NYSE:AVD) and Bioceres Crop Solutions (NASDAQ:BIOX) are both small-cap materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

American Vanguard has higher revenue and earnings than Bioceres Crop Solutions. American Vanguard is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$510.32M	0.09	-$49.88M	-$1.90	N/A
Bioceres Crop Solutions	$238.30M	0.09	-$54.40M	-$3.66	N/A

American Vanguard has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, Bioceres Crop Solutions has a beta of 0.47, suggesting that its share price is 53% less volatile than the broader market.

79.0% of American Vanguard shares are held by institutional investors. Comparatively, 17.7% of Bioceres Crop Solutions shares are held by institutional investors. 5.6% of American Vanguard shares are held by insiders. Comparatively, 2.3% of Bioceres Crop Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

American Vanguard has a net margin of -10.70% compared to Bioceres Crop Solutions' net margin of -94.76%. American Vanguard's return on equity of -9.05% beat Bioceres Crop Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-10.70%	-9.05%	-2.78%
Bioceres Crop Solutions	-94.76%	-39.11%	-9.45%

Bioceres Crop Solutions has a consensus target price of $2.00, indicating a potential upside of 509.20%. Given Bioceres Crop Solutions' stronger consensus rating and higher probable upside, analysts plainly believe Bioceres Crop Solutions is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bioceres Crop Solutions	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Bioceres Crop Solutions had 2 more articles in the media than American Vanguard. MarketBeat recorded 3 mentions for Bioceres Crop Solutions and 1 mentions for American Vanguard. American Vanguard's average media sentiment score of 0.95 beat Bioceres Crop Solutions' score of 0.44 indicating that American Vanguard is being referred to more favorably in the media.

Company	Overall Sentiment
American Vanguard	Positive
Bioceres Crop Solutions	Neutral

Summary

American Vanguard beats Bioceres Crop Solutions on 11 of the 15 factors compared between the two stocks.

How does American Vanguard compare to Senestech?

American Vanguard (NYSE:AVD) and Senestech (NASDAQ:SNES) are both small-cap materials companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk.

79.0% of American Vanguard shares are held by institutional investors. Comparatively, 5.2% of Senestech shares are held by institutional investors. 5.6% of American Vanguard shares are held by insiders. Comparatively, 2.2% of Senestech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

American Vanguard has a net margin of -10.70% compared to Senestech's net margin of -294.73%. American Vanguard's return on equity of -9.05% beat Senestech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-10.70%	-9.05%	-2.78%
Senestech	-294.73%	-71.89%	-51.98%

In the previous week, American Vanguard and American Vanguard both had 1 articles in the media. American Vanguard's average media sentiment score of 0.95 beat Senestech's score of 0.00 indicating that American Vanguard is being referred to more favorably in the media.

Company	Overall Sentiment
American Vanguard	Positive
Senestech	Neutral

American Vanguard has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Senestech has a beta of 0.25, suggesting that its stock price is 75% less volatile than the broader market.

Senestech has lower revenue, but higher earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$510.32M	0.09	-$49.88M	-$1.90	N/A
Senestech	$2.22M	1.64	-$6.38M	-$1.37	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Senestech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

American Vanguard beats Senestech on 8 of the 12 factors compared between the two stocks.

How does American Vanguard compare to Corteva?

Corteva (NYSE:CTVA) and American Vanguard (NYSE:AVD) are both materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

Corteva pays an annual dividend of $0.72 per share and has a dividend yield of 5.4%. American Vanguard pays an annual dividend of $0.03 per share and has a dividend yield of 1.9%. Corteva pays out 47.7% of its earnings in the form of a dividend. American Vanguard pays out -1.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Corteva has raised its dividend for 5 consecutive years. Corteva is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Corteva has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market.

81.5% of Corteva shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 0.2% of Corteva shares are owned by company insiders. Comparatively, 5.6% of American Vanguard shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Corteva presently has a consensus target price of $64.00, suggesting a potential upside of 383.60%. Given Corteva's stronger consensus rating and higher possible upside, equities analysts clearly believe Corteva is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Corteva	1 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.65
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Corteva has a net margin of 5.66% compared to American Vanguard's net margin of -10.70%. Corteva's return on equity of 10.18% beat American Vanguard's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Corteva	5.66%	10.18%	6.00%
American Vanguard	-10.70%	-9.05%	-2.78%

In the previous week, Corteva had 38 more articles in the media than American Vanguard. MarketBeat recorded 39 mentions for Corteva and 1 mentions for American Vanguard. American Vanguard's average media sentiment score of 0.95 beat Corteva's score of 0.40 indicating that American Vanguard is being referred to more favorably in the news media.

Company	Overall Sentiment
Corteva	Neutral
American Vanguard	Positive

Corteva has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Corteva	$17.40B	0.51	$1.09B	$1.51	8.76
American Vanguard	$510.32M	0.09	-$49.88M	-$1.90	N/A

Summary

Corteva beats American Vanguard on 15 of the 19 factors compared between the two stocks.

How does American Vanguard compare to Nutrien?

American Vanguard (NYSE:AVD) and Nutrien (NYSE:NTR) are both materials companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 63.1% of Nutrien shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by company insiders. Comparatively, 3.1% of Nutrien shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

American Vanguard has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Nutrien has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

In the previous week, Nutrien had 9 more articles in the media than American Vanguard. MarketBeat recorded 10 mentions for Nutrien and 1 mentions for American Vanguard. American Vanguard's average media sentiment score of 0.95 beat Nutrien's score of 0.51 indicating that American Vanguard is being referred to more favorably in the media.

Company	Overall Sentiment
American Vanguard	Positive
Nutrien	Positive

Nutrien has a net margin of 8.44% compared to American Vanguard's net margin of -10.70%. Nutrien's return on equity of 8.88% beat American Vanguard's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-10.70%	-9.05%	-2.78%
Nutrien	8.44%	8.88%	4.27%

Nutrien has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$510.32M	0.09	-$49.88M	-$1.90	N/A
Nutrien	$26.89B	1.20	$2.27B	$4.94	13.67

Nutrien has a consensus price target of $81.15, suggesting a potential upside of 20.20%. Given Nutrien's stronger consensus rating and higher possible upside, analysts clearly believe Nutrien is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nutrien	1 Sell rating(s)	4 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.73

American Vanguard pays an annual dividend of $0.03 per share and has a dividend yield of 1.9%. Nutrien pays an annual dividend of $2.20 per share and has a dividend yield of 3.3%. American Vanguard pays out -1.6% of its earnings in the form of a dividend. Nutrien pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nutrien has raised its dividend for 7 consecutive years. Nutrien is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Nutrien beats American Vanguard on 14 of the 19 factors compared between the two stocks.

How does American Vanguard compare to CF Industries?

American Vanguard (NYSE:AVD) and CF Industries (NYSE:CF) are both materials companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, CF Industries had 28 more articles in the media than American Vanguard. MarketBeat recorded 29 mentions for CF Industries and 1 mentions for American Vanguard. American Vanguard's average media sentiment score of 0.95 beat CF Industries' score of 0.70 indicating that American Vanguard is being referred to more favorably in the media.

Company	Overall Sentiment
American Vanguard	Positive
CF Industries	Positive

CF Industries has a consensus price target of $121.11, suggesting a potential upside of 8.45%. Given CF Industries' stronger consensus rating and higher possible upside, analysts plainly believe CF Industries is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CF Industries	3 Sell rating(s)	12 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.30

CF Industries has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than CF Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$510.32M	0.09	-$49.88M	-$1.90	N/A
CF Industries	$7.08B	2.39	$1.46B	$13.49	8.28

CF Industries has a net margin of 27.12% compared to American Vanguard's net margin of -10.70%. CF Industries' return on equity of 24.41% beat American Vanguard's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-10.70%	-9.05%	-2.78%
CF Industries	27.12%	24.41%	13.74%

79.0% of American Vanguard shares are held by institutional investors. Comparatively, 93.1% of CF Industries shares are held by institutional investors. 5.6% of American Vanguard shares are held by company insiders. Comparatively, 0.5% of CF Industries shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

American Vanguard pays an annual dividend of $0.03 per share and has a dividend yield of 1.9%. CF Industries pays an annual dividend of $2.40 per share and has a dividend yield of 2.1%. American Vanguard pays out -1.6% of its earnings in the form of a dividend. CF Industries pays out 17.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CF Industries has raised its dividend for 3 consecutive years. CF Industries is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

American Vanguard has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, CF Industries has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

Summary

CF Industries beats American Vanguard on 16 of the 20 factors compared between the two stocks.

Get American Vanguard News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVD vs. The Competition

Export

Metric	American Vanguard	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$50.45M	$10.89B	$4.72B	$22.94B
Dividend Yield	N/A	2.97%	4.77%	3.72%
P/E Ratio	-0.85	34.07	24.40	28.60
Price / Sales	0.09	53.09	15,459.35	15.21
Price / Cash	3.72	14.74	24.94	37.72
Price / Book	0.24	3.12	9.83	4.72
Net Income	-$49.88M	$228.59M	$159.32M	$1.07B
7 Day Performance	-7.39%	-0.39%	-0.83%	0.35%
1 Month Performance	-28.92%	-4.01%	-4.71%	-2.93%
1 Year Performance	-68.04%	16.46%	15.50%	9.26%

American Vanguard Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVD American Vanguard	1.2186 of 5 stars	$1.62 -5.4%	N/A	-69.2%	$50.45M	$510.32M	N/A	739	Short Interest Increase
BIOX Bioceres Crop Solutions	2.1506 of 5 stars	$0.35 -1.7%	$2.00 +468.2%	-76.9%	$22.98M	$238.30M	N/A	751	Short Interest Increase
SNES Senestech	1.6048 of 5 stars	$0.66 +4.6%	N/A	-83.8%	$3.66M	$2.22M	N/A	24	Gap Down
CTVA Corteva	4.8105 of 5 stars	$77.49 -0.3%	$91.90 +18.6%	-78.9%	$51.57B	$17.40B	51.19	21,500	Trending News Analyst Upgrade Options Volume Analyst Revision Gap Up
NTR Nutrien	4.6228 of 5 stars	$71.67 -0.4%	$81.15 +13.2%	+10.4%	$34.03B	$26.89B	14.47	25,500	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVD) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Vanguard (AVD) Competitors

AVD vs. BIOX, SNES, CTVA, NTR, and CF

How does American Vanguard compare to Bioceres Crop Solutions?

Summary

How does American Vanguard compare to Senestech?

Summary

How does American Vanguard compare to Corteva?

Summary

How does American Vanguard compare to Nutrien?

Summary

How does American Vanguard compare to CF Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVD vs. The Competition

American Vanguard Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Vanguard (AVD) Competitors

AVD vs. BIOX, SNES, CTVA, NTR, and CF

How does American Vanguard compare to Bioceres Crop Solutions?

Which has preferable valuation & earnings, AVD or BIOX?

Which has more risk and volatility, AVD or BIOX?

Do insiders and institutionals have more ownership in AVD or BIOX?

Is AVD or BIOX more profitable?

Do analysts rate AVD or BIOX?

Does the media prefer AVD or BIOX?

Summary

How does American Vanguard compare to Senestech?

Do institutionals and insiders have more ownership in AVD or SNES?

Is AVD or SNES more profitable?

Does the media favor AVD or SNES?

Which has more volatility & risk, AVD or SNES?

Which has better earnings & valuation, AVD or SNES?

Do analysts rate AVD or SNES?

Summary

How does American Vanguard compare to Corteva?

Is CTVA or AVD a better dividend stock?

Which has more risk and volatility, CTVA or AVD?

Do institutionals and insiders believe in CTVA or AVD?

Do analysts rate CTVA or AVD?

Is CTVA or AVD more profitable?

Does the media refer more to CTVA or AVD?

Which has preferable valuation and earnings, CTVA or AVD?

Summary

How does American Vanguard compare to Nutrien?

Do institutionals & insiders hold more shares of AVD or NTR?

Which has more volatility & risk, AVD or NTR?

Does the media refer more to AVD or NTR?

Is AVD or NTR more profitable?

Which has stronger earnings & valuation, AVD or NTR?

Do analysts recommend AVD or NTR?

Is AVD or NTR a better dividend stock?

Summary

How does American Vanguard compare to CF Industries?

Does the media refer more to AVD or CF?

Do analysts prefer AVD or CF?

Which has higher earnings and valuation, AVD or CF?

Is AVD or CF more profitable?

Do institutionals and insiders hold more shares of AVD or CF?

Is AVD or CF a better dividend stock?

Which has more volatility & risk, AVD or CF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVD vs. The Competition

American Vanguard Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools